Targeting the progression of Parkinson's disease. - sprookjes - yvandenbroek - TriplyDB

Targeting the progression of Parkinson's disease.

Targeting the progression of Parkinson's disease.

http://www.wikidata.org/entity/Q37299619

about

Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases Melatonin and Other Tryptophan Metabolites Produced by Yeasts: Implications in Cardiovascular and Neurodegenerative Diseases Cellular models to investigate biochemical pathways in Parkinson's disease Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease.Molecular imaging of cell death in an experimental model of Parkinson's disease with a novel apoptosis-targeting peptide.Predictive association of copper metabolism proteins with Alzheimer's disease and Parkinson's disease: a preliminary perspective.Selective brain penetrable Nurr1 transactivator for treating Parkinson's disease.Parkinson's disease dementia and potential therapeutic strategies.NADPH oxidase and neurodegeneration Mathematical models of α-synuclein transport in axons.The novel tetramethylpyrazine bis-nitrone (TN-2) protects against MPTP/MPP+-induced neurotoxicity via inhibition of mitochondrial-dependent apoptosis.The effect of red grape juice and exercise, and their combination on parkinson(')s disease in rats Neuroprotective effect of aqueous extract of Selaginella delicatula as evidenced by abrogation of rotenone-induced motor deficits, oxidative dysfunctions, and neurotoxicity in mice.Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.Polygalasaponin F against rotenone-induced apoptosis in PC12 cells via mitochondria protection pathway.Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases.Aqueous Extract of Dendropanax morbiferus Leaves Effectively Alleviated Neuroinflammation and Behavioral Impediments in MPTP-Induced Parkinson's Mouse Model.Characteristics of the mitochondrial and cellular uptake of MPP+, as probed by the fluorescent mimic, 4'I-MPP

P2860

Q26765787-29175CB4-64CF-4436-9A18-2104028CE8C3 Q26772733-3E2B32C0-2B03-4B76-9722-E39DE1A8D0D3 Q26829742-4FBD56B5-788F-4A3D-8137-6D292F831844 Q30512976-FDBC64BC-59BA-43B3-96A3-235FAAC613DC Q34184725-0512D00F-F6FE-48C7-A1A1-B989E75A4663 Q34398474-BE9407CC-9D1D-47CA-8C23-A1B774F9F0E0 Q36946543-7937DBD2-B357-41CA-8248-826435210CE4 Q37825631-5226A284-1E0F-4F1F-873F-502E81FE3B57 Q38111373-1ED17029-3FB5-4813-A929-E5411496382F Q38981601-323DD041-D447-4E98-8C33-6B739D2258A6 Q39063048-CF4428F3-78BB-496C-9CAC-DB4650C143CE Q41497337-B87A49D7-3664-43C9-A3FA-75040835D355 Q44593403-298729D0-7686-417B-B332-C297BDC645EC Q45873810-1B8FAE6A-83ED-4891-BAC7-76146AA0F725 Q46952414-3AF6BF84-220E-41D2-AAFB-D3F913C307CE Q51764192-80A32E78-04E1-44C9-BDDA-58A9C73EFD4A Q55049102-2A66D614-1479-4229-A13F-94C2C408B560 Q58715913-F01780B3-DEF9-401B-9632-ED3190602B4D

P2860

Targeting the progression of Parkinson's disease.

http://www.wikidata.org/entity/Q37299619

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting the progression of Parkinson's disease.

@en

Targeting the progression of Parkinson's disease.

@nl

type

label

Targeting the progression of Parkinson's disease.

@en

Targeting the progression of Parkinson's disease.

@nl

prefLabel

Targeting the progression of Parkinson's disease.

@en

Targeting the progression of Parkinson's disease.

@nl

P1433

Q37299619-5D4DD9EE-9850-4D39-BD07-40BC65527CD8

P1476

Q37299619-8231EA82-E779-46C3-8C2A-62C3C2B80EDB

P2093

Q37299619-029703FC-DD81-4244-A305-3CACAF2B9D73

Q37299619-1FE13A6D-3FE9-4C4A-B97C-4E57285135C2

Q37299619-3EDB54F7-F3EE-47F0-A6D7-DA71B30C0447

Q37299619-84AC9039-4096-4EBB-8FB1-9BAEDB67860E

Q37299619-9185F872-5638-47FB-8CF8-92DEB623B621

P2860

Q37299619-0048C421-1939-4C2E-B6B0-61FE9AAC3886

Q37299619-014F123F-10D0-4388-8CC5-5EC38CD76579

Q37299619-01DA36FA-8266-4CDE-B9B2-F07E05280E6B

Q37299619-01E5E20D-0C34-41C2-B4E4-5B02BDFCBBDA

Q37299619-03BA1D69-AC72-4192-BC9F-B3E8E124DF33

Q37299619-050E063C-360D-45F1-8028-C535D4002490

Q37299619-05112CCE-B484-44C6-AF01-E61C482EA59F

Q37299619-060014BF-182D-49DD-9222-85AF59C5C529

Q37299619-071A44AF-17B1-46EB-9275-DCA44DFD3EA2

Q37299619-076A1AB6-BD68-48B4-B25A-A51AF512D6F1

P304

Q37299619-6D51989F-6AE9-4D5E-A9C3-170F051B5724

P31

Q37299619-33FAF924-D69E-4BE7-BCAD-BE97CDDADFBC

P356

Q37299619-8E1AE10C-485B-4F31-A39E-83AAECFCD539

P433

Q37299619-B2EC9A28-BECA-4CAE-B911-928850FFC53A

P478

Q37299619-89E78549-7118-4F32-B384-BB5283007DCA

P50

Q37299619-42430528-124A-4A0F-B40D-F29B2EACBDCD

Q37299619-802AE8DB-FCBB-4328-9D69-BB44AB90649C

P577

Q37299619-88696551-0C5A-486E-81FB-4606EE8E8B33

P5875

Q37299619-71A3D097-0F9F-4E3C-88AB-CDBCCFAE0B66

P698

Q37299619-3202CDBA-94D6-4998-B3C1-E6252E7667AA

P921

Q37299619-2B3C66BA-1AD6-4558-9089-3463DA35C9C0

P932

Q37299619-AB539D39-602C-48D4-B609-FAFD392F661B

P356

157015909787602814

P1433

Current Neuropharmacology

P1476

Targeting the progression of Parkinson's disease

@en

P2093

D I Finkelstein

http://www.w3.org/2001/XMLSchema#string

D Moses

http://www.w3.org/2001/XMLSchema#string

J L George

http://www.w3.org/2001/XMLSchema#string

R A Cherny

http://www.w3.org/2001/XMLSchema#string

S Mok

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

A role for alpha-synuclein in the regulation of dopamine biosynthesis

Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability

Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36.

Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study

Occupational exposures to solvents and aluminium and estimated risk of Alzheimer's disease

P304

9-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/157015909787602814

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26781443

http://www.w3.org/2001/XMLSchema#string

P698

19721815

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2724666

http://www.w3.org/2001/XMLSchema#string